×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [9]
北京大学 [6]
长春应用化学研究所 [4]
中国医学科学院 北京... [3]
厦门大学 [2]
上海药物研究所 [2]
更多...
内容类型
期刊论文 [34]
其他 [1]
发表日期
2019 [6]
2018 [1]
2017 [5]
2016 [4]
2015 [1]
2014 [6]
更多...
学科主题
Genetics &... [1]
Oncology [1]
Pharmacolo... [1]
Research &... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共35条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study
期刊论文
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 卷号: 47, 期号: 1
作者:
Liu, Lunfei
;
Chen, Jisu
;
Xu, Jinhua
;
Yang, Qinping
;
Gu, Chaoying
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2019/12/04
Sublingual immunotherapy
atopic dermatitis
Dermatophagoides farina Drops
clinical phase II trial
Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study
期刊论文
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 卷号: 47, 期号: 1
作者:
Liu, Lunfei
;
Chen, Jisu
;
Xu, Jinhua
;
Yang, Qinping
;
Gu, Chaoying
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2019/12/05
Sublingual immunotherapy
atopic dermatitis
Dermatophagoides farina Drops
clinical phase II trial
AAA: triple adaptive Bayesian designs for the identification of optimal dose combinations in dual-agent dose finding trials
期刊论文
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2019, 卷号: 68, 期号: 2
作者:
Lyu, Jiaying
;
Ji, Yuan
;
Zhao, Naiqing
;
Catenacci, Daniel V. T.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
Adaptive cohort division
Bayesian inference
Dose combination
Hierarchical models
Markov chain Monte Carlo simulation
Phase I-II clinical trial
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
期刊论文
ONCOLOGIST, 2019, 卷号: 24, 期号: 8
作者:
Zhou, Ai-Ping
;
Bai, Yuxian
;
Song, Yan
;
Luo, Hong
;
Ren, Xiu-Bao
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2019/12/05
Anlotinib
Metastatic renal cell cancer
Phase II clinical trial
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
期刊论文
ONCOLOGIST, 2019, 卷号: 24, 期号: 8, 页码: E702-E708
作者:
Zhou, Ai-Ping
;
Bai, Yuxian
;
Song, Yan
;
Luo, Hong
;
Ren, Xiu-Bao
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/12/11
Anlotinib
Metastatic renal cell cancer
Phase II clinical trial
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
期刊论文
2019, 卷号: 24, 期号: 8, 页码: E702-E708
作者:
Zhou, Ai-Ping
;
Bai, Yuxian
;
Song, Yan
;
Luo, Hong
;
Ren, Xiu-Bao
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2020/01/03
Anlotinib
Metastatic renal cell cancer
Phase II clinical trial
Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osimertinib
期刊论文
CLINICAL CANCER RESEARCH, 2018, 卷号: 24, 期号: 11, 页码: 2594-2604
作者:
Liu, Shengwu
;
Hai, Josephine
;
Wang, Xiaoen
;
Quinn, Max M.
;
Gao, Peng
收藏
  |  
浏览/下载:82/0
  |  
提交时间:2019/04/28
Receptor Tyrosine Kinase
Phase-ii Trial
Bromodomain Inhibition
Combination Therapy
Acquired-resistance
Domain Mutations
Bet Bromodomains
Breast-cancer
Egfr
Mutant
Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial
期刊论文
AGE AND AGEING, 2017, 卷号: 46, 期号: 5
作者:
Xiao, Shifu
;
Wang, Tao
;
Ma, Xiuqiang
;
Qin, Yingyi
;
Li, Xia
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/04
older people
octohydroaminoacridine
Alzheimer's disease
treatment
novel drug
Phase II trial
Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma
期刊论文
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 卷号: 23, 期号: 3
作者:
Zhu, Han-Ting
;
Ai, Da-Shan
;
Tang, Hua-Rong
;
Badakhshi, Harun
;
Fan, Jian-Hong
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/05
Chemoradiotherapy
Long-term result
Loco-regionally advanced esophageal cancer
Phase II trial
Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial
期刊论文
Age and Ageing, 2017, 卷号: 46, 期号: 5, 页码: 767-773
作者:
Xiao, Shifu
;
Wang, Tao
;
Ma, Xiuqiang
;
Qin, Yingyi
;
Li, Xia
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/03
older people
octohydroaminoacridine
Alzheimer's disease
treatment
novel drug
Phase II trial
©版权所有 ©2017 CSpace - Powered by
CSpace